Background {#Sec1}
==========

*Filamin A* is a 280-kD protein that crosslinks actin filaments into orthogonal networks in cortical cytoplasm and participates in the anchoring of membrane proteins for the actin cytoskeleton. Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. Filamin A, encoded by the *FLNA* gene, is a widely expressed protein that regulates reorganization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes, and second messengers, thus mutations in the gene encoding filamin A (*FLNA*) lead to diseases with high phenotypic diversity including the following: periventricular nodular heterotopia (PNH), skeletal dysplasia, otopalatodigital spectrum disorders such as Melnick-Needles syndrome and frontometaphyseal dysplasia \[[@CR1]--[@CR5]\], cardiovascular abnormalities that include patent ductus arteriosus (PDA), valvular disease, aortic root dilatation and aneurysms, Ehlers-Danlos syndrome-like phenotype \[[@CR6]--[@CR8]\], and coagulopathy with thrombocytopenia \[[@CR9]\]. Recently, Masurel-Paulet *et al*. \[[@CR1]\], de Wit and colleagues \[[@CR10]\], and Lord *et al*. \[[@CR11]\] reported associations between pulmonary diseases in both sexes with substantial heterogeneity in manifestations and lethality. Here, we report the case of a female child with a novel *FLNA* gene mutation who developed significant lung disease and unique angiogenesis.

Case presentation {#Sec2}
=================

Our patient is a 1-year-old Saudi female child who was referred from another hospital after PDA ligation, left inguinal hernia repair, accidental fracture of her right ulna and radius, and prolonged mechanical ventilation for severe respiratory syncytial virus infection complicated by acute respiratory distress syndrome. The patient was sent to our hospital for further evaluation due to ongoing respiratory distress and hypoxemia. Our patient was the third child of nonconsanguineous Saudi parents and was born via cesarean section at 36 weeks gestation due to fetal distress. The child was admitted to the neonatal intensive care unit for 5 days because of respiratory distress and was ventilated for 36 hours. The mother has epilepsy and the father has been diagnosed with Behcet\'s disease. Since the age of 2 months, the child had multiple lengthy admissions in different hospitals (for 1 to 3 months at a time) for recurrent cyanotic events, respiratory distress, frequent choking with feeding, and significant vomiting. The child had accumulated the following diagnoses: severe gastroesophageal reflux disease (GERD), failure to thrive requiring prolonged nasogastric tube feeding, patent ductus arteriosus, pulmonary hypertension, anoxic convulsions, chronic lung disease with prolonged oxygen dependency, reversible bronchospasm, left external iliac vein thrombosis, and developmental delay. She had two prior prolonged stays at our institution.

The first admission was due to rhinovirus infection and clinically diagnosed recurrent aspiration secondary to aberrant right subclavian artery (dysphagia lusoria) with prolonged oxygen therapy. The second admission was for respiratory failure that required prolonged intubation including high-frequency oscillatory ventilation complicated by recurrent lung atelectasis and right lung pneumothorax. She failed multiple trials of extubation and unfortunately died of cardiac arrest due to sepsis while receiving maximal supportive therapy. An initial physical examination during the first admission revealed a baby girl in poor health with the following clinical values: moderate respiratory distress and a respiratory rate of 70/min, heart rate of 144/min, blood pressure of 101/47 with saturation of 95% on 1.5 L/min, body weight of 5.9 kg (below the third percentile), and height of 69 cm (at the tenth percentile).The child had diminished breath sounds bilaterally with a prolonged expiratory phase, wheezing, and scattered crackles posteriorly, mild hypotonia, and significant hyperlaxity. Investigations showed normal sweat chloride level, and immune function testing was normal. A chest X-ray (Fig. [1](#Fig1){ref-type="fig"}) showed multiple subsegmental atelectasis and areas of air trapping. Computed tomography and angiography of her chest (Fig. [2](#Fig2){ref-type="fig"}) revealed bilateral lower lobe airspace disease, hyperinflation of the right middle lobe and left upper lobe including the lingual, and an enlarged main pulmonary artery. The sagittal view (Fig. [3](#Fig3){ref-type="fig"}) showed a right aberrant subclavian artery causing posterior compression to the esophagus at the level of the T4 vertebra and minimal compression in the posterior trachea. An echocardiogram showed no residual PDA or significant evidence of pulmonary hypertension. Barium administration (Fig. [4](#Fig4){ref-type="fig"}) showed external compression along the posterior wall of the proximal third of the esophagus, which was causing significant narrowing of the esophageal lumen. The pH probe showed no significant GERD. Upper gastrointestinal endoscopy showed there was a narrowed and compressed area located 18 cm into the esophagus at T4, and was identified with marked pulsation. The flexible bronchoscopy showed complete ring and narrowing of the lower third of the trachea. A lung biopsy (Fig. [5](#Fig5){ref-type="fig"}) showed alveolated lung parenchyma with alveolar simplification, in which alveoli do not show age-appropriate normal architecture, compared with the normal alveolar architecture (Fig. [6](#Fig6){ref-type="fig"}). There was no magnetic resonance imaging (MRI) of the brain because our patient\'s condition did not allow it.Fig. 1Chest X-ray anteroposterior view shows multiple subsegmental atelectasis, areas of air trapping and osteopeniaFig. 2Computed tomography angiography axial view below bifurcation of carina shows basal lung atelectasis, lung hyperinflation, and enlarged main pulmonary arteryFig. 3Computed tomography angiography sagittal view shows right aberrant subclavian artery posterior compression to the esophagus at level of T4 vertebra and minimal compression in the posterior tracheaFig. 4Barium meal shows external compression noted along posterior wall of proximal third of the thoracic esophagus causing significant narrowing of esophageal lumenFig. 5Alveolated lung parenchyma (black arrows) with alveolar simplification. *Small yellow arrow*: from the microscope that is probably not relevantFig. 6Normal alveolar septation

Gene analysis {#Sec3}
-------------

Molecular testing for *FLNA*-related disorders in our patient showed a new pathogenic variant of one copy of c.3153dupC in exon 21 in the *FLNA* gene. This variant has not been reported in individuals with *FLNA*-related disorders but is expected to cause disease.

Discussion {#Sec4}
==========

In this case report, we describe another confirmatory mutation in the gene encoding filamin A (*FLNA*) in a female child with lung disease. Our patient was a female child who was confirmed to have a pathogenic variant of the *FLNA* gene c.3153dupC. This mutation has not been reported in individuals with *FLNA*-related disorders but is expected to cause disease. Similar to other reported cases, our child also manifested clinical symptoms at an early age \[[@CR10], [@CR11]\]. She had respiratory distress at birth and then had recurrent lower respiratory tract infections/bronchiolitis, bilateral lung emphysema with basal atelectasis, bronchospasm, pulmonary artery hypertension, and long oxygen and mechanical ventilatory dependency after 2 months of age. A lung biopsy showed alveolated lung parenchyma with alveolar simplification similar to the finding by Lord *et al*. \[[@CR11]\]. This child also manifested associated clinical features reported with other filamin gene mutations including patent ductus arteriosis (PDA), hypotonia, joint laxity, and developmental delay \[[@CR10]\]. These clinical and histological features are similar to cases reported with the pulmonary phenotype of *FLNA* (Table [1](#Tab1){ref-type="table"}). However, an unusual clinical manifestation in our case is severe reflux that caused recurrent aspiration symptoms and dysphagia lusoria (secondary to aberrant right subclavian artery that caused significant esophageal compression). This abnormal angiogenesis has been reported only in *FLNA*-null mice, which have vascular endothelial cells that show defective cell--cell contacts and adherens junctions. The result is abnormal angiogenesis with disorganized blood vessels and aberrant branching \[[@CR7], [@CR12]\]. There are other possible pulmonary phenotypes of *FLNA* gene mutation suggested due to its role in T cell activation, interleukin production \[[@CR13]\], inflammatory signaling \[[@CR14]\], and interaction with the cystic fibrosis transmembrane conductance regulator \[[@CR15]\]. There has been no specific sensitivity to infections observed in *FLNA* patients \[[@CR10]\]. However, our patient was noted to have severe prolonged courses of viral or bacterial infections. The pathogenic variant of *FLNA* gene mutation in our reported case is not confirmed to have association with periventricular nodular heterotopias (PNH), and our patient was too ill to complete brain MRI. The patient's mother has epilepsy beginning in the third decade of life. The patient's father has Behcet's disease, which is highly consistent with other reports of PNH \[[@CR8], [@CR16], [@CR17]\].Table 1Features of reported cases of filamin A mutationMasurel-Paulet *et al.* \[[@CR1]\]de Wit *et al.* \[[@CR10]\]Lord *et al*. \[[@CR11]\]This caseGenetic mutationMosaic nonsense *filamin A* mutation (c.994delG.P.K331X)Missense *filamin A* mutation (c.220G\>P.G74R )Truncating *filamin A* mutation (c.5683G\>T,p.G1895\*)Pathogenic variant (c.3153dupC) in exon 21 *filamin A* geneSexMaleFemaleFemaleFemaleBirthTerm with uncomplicated perinatal courseTerm with uncomplicated perinatal coursePremature at 30 weeks mild respiratory distress resolved after 48 hoursPremature at 36 weeks with respiratory distress, needed ventilation for first 36 hoursAge at presentation1.5 months3 months24 days2 monthsPulmonary manifestation and pathologyTachypnea, recurrent respiratory infections, asthma, prolonged oxygen dependence, lung atelectasis and lung cysts, tracheobronchomalacia, pulmonary arterial hypertensionDyspnea, recurrent respiratory infections, prolonged oxygen dependence until 1 year and 7 months of age. Emphysema of right middle lobe, bronchomalacia of right bronchial treeTachypnea with desaturations, pulmonary arterial hypertension, oxygen dependence until 22 months of age bilateral pulmonary atelectasis and cysts. TracheobronchomalaciaRecurrent cyanotic events, respiratory distress, episodes of choking and vomiting, with associated bronchospasm pulmonary arterial hypertension, prolonged oxygen and ventilator dependence until death at 15 months of age, bilateral pulmonary emphysema and basal atelectasis tracheal stenosisChest X-rayBilateral subsegmental atelectasis with hyperlucent areas in both mid zonesCystic pulmonary lesions alternating with heterogeneous areas of atelectasisMultiple subsegmental atelectasis and areas of air trappingChest CTscanWidespread peribronchial thickening, subsegmental collapse, fluid within oblique fissure, eventration of the left hemidiaphragmSevere lobar emphysema of right middle lobe with displacement of medistinal structures to left and compression of left upper lobePatchy ground-glass appearance with area of hyperinflation and cystic pulmonary lesions alternating with heterogeneous areas of atelectasis and thickening of interlobar septaBilateral lower lobe airspace diseases, hyperinflation of both upper lobes, enlarged main pulmonary artery, right aberrant subclavian artery, compressing esophagus and tracheaSurgerySubtotal upper lobectomy at age of\
8 months for lobar emphysema.Lobectomy of right middle lobe for lobar emphysemaLung histology resultsPanpulmonary emphysema with global absence of bronchial cartilage and hypertensive pulmonary vascular diseaseLung emphysema without inflammationMild to moderate chronic lung disease with associated alveolar simplification and pulmonary hypertensionAlveolated lung parenchyma with alveolar simplificationThe associated nonpulmonary featuresPeriventricular nodular heterotopia with left cerebellar hemisphere hypoplasia and cisterna magna, truncal hypotonia, PDA, aortic root dilatation, bifid right urinary drainage system supraumbilical hernia, macrothrombocytesPeriventricular nodular heterotopia, with an enlarged retrocerebellar cyst, secundum atrial septal defect and coarctation of the aorta, hypotonia, severe hyperlaxityPeriventricular nodular heterotopia, secundum atrial septal defect, mild axial hypotoniaSuspected periventricular nodular heterotopia, PDA, angiogenesis causing dysphagia lusoria, hypotonia and joint laxityOutcomesFollow-up to 6 yearsFollow-up to 3 yearsFollow-up to 22 monthsDeath at 15 months*CT* computed tomography, *PDA* patent ductus arteriosus

Conclusions {#Sec5}
===========

In conclusion, we support the three previous reports in the literature, stating that there is an association between *FLNA* gene mutation and lung disease. The lung disease is a lethal condition likely manifested by early onset of pneumonia and recurrent bronchiolitis, subsequent asthma, pulmonary hypertension, and long-term oxygen dependency with underlying lung emphysema or lung cysts. *FLNA* mutation is also associated with airway anomalies such as tracheal stenosis (as in our patient) or tracheobronchomalacia. In addition, there are other diverse associated clinical manifestations.

Consent {#Sec6}
=======

Written informed consent was obtained from the patient's legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
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